Category Archive for: ‘Eli Lilly’

Lilly Pulls FDA Application For Cymbalta For Pain

Nov 28, 2008 CHICAGO (Reuters) – Eli Lilly and Co (LLY.N: Quote, Profile, Research, Stock Buzz) said on Friday it withdrew an application to market its anti-depressant Cymbalta for the management of chronic pain because U.S. health regulators raised questions about the drug’s effectiveness and dosing. Lilly said it made its decision to pull the supplemental New Drug Application for …

Read More

Drug Maker to Report Fees to Doctors

This is a step in the right direction. Transparency is needed where conflict may exist in how a doctor, who is a paid consultant to a drug maker, can serve his patients and receive payments from the drug maker simultaneously. This transparency should extend to any relationship between practicing doctors and equipment makers, hospitals, consulting companies and others. Larry Ho, …

Read More

Cymbalta Eases Back Pain In Study

Mon Aug 25, 2008 NEW YORK (Reuters) – Eli Lilly and Co’s Cymbalta depression treatment significantly reduced chronic low back pain in a relatively small clinical trial, the company said on Monday. Data from the 236-patient trial, which lasted 13 weeks and compared the effectiveness of Cymbalta with placebos, were presented at the annual congress of the European Federation of …

Read More